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In Brief
Zhu et al. examine the mechanism
regulating availability of insulin granules
for secretion in pancreatic b cells,
showing that non-directional vesicular
transport along Golgi-derived
microtubules limits granule dwelling at
the cell periphery. Consistently,
microtubule depolymerization facilitates
secretion in vitro and in mice and glucose
stimuli remodel microtubules to control
secretion.
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For glucose-stimulated insulin secretion (GSIS), in-
sulin granules have to be localized close to the
plasma membrane. The role of microtubule-depen-
dent transport in granule positioning and GSIS has
been debated. Here, we report that microtubules,
counterintuitively, restrict granule availability for
secretion. In b cells, microtubules originate at the
Golgi and form a dense non-radial meshwork. Non-
directional transport along these microtubules limits
granule dwelling at the cell periphery, restricting
granule availability for secretion. High glucose desta-
bilizes microtubules, decreasing their density; such
local microtubule depolymerization is necessary for
GSIS, likely because granule withdrawal from the
cell periphery becomes inefficient. Consistently,
microtubule depolymerization by nocodazole blocks
granule withdrawal, increases their concentration
at exocytic sites, and dramatically enhances GSIS
in vitro and in mice. Furthermore, glucose-driven
MT destabilization is balanced by new microtubule
formation, which likely prevents over-secretion.
Importantly, microtubule density is greater in
dysfunctional b cells of diabetic mice.
INTRODUCTION
Glucose-stimulated insulin secretion (GSIS) in pancreatic b cells
maintains glucose homeostasis and prevents diabetes. Despite
decades of studies, our knowledge about what controls the pre-
cise amount of insulin release on a given stimulus is incomplete.
Each b cell has over 10,000 secretory vesicles containing insulin
(also known as dense core granules or insulin granules) (Dean,
1973; Olofsson et al., 2002); yet sustained high glucose exposure
only releases several hundred granules, suggesting that specific
mechanisms regulate the releasability of most granules (Rors-
man and Renstro¨m, 2003).
A key mechanism that restricts insulin secretion is controlling
the number of insulin granules located in the proximity of the656 Developmental Cell 34, 656–668, September 28, 2015 ª2015 Elsplasmamembrane, which is a net result from the delivery of gran-
ules to the plasma membrane and their withdrawal back to the
cell interior. It is thought that microtubules (MTs), 25 nm-thick dy-
namic cytoskeletal polymers ofa/b tubulin dimers, play an essen-
tial role in insulin granule positioning. In 1968, Lacy et al. (1968)
proposed that MTs are involved in insulin granule linkage to sites
of secretion at the plasmamembrane. Thereafter, several studies
suggested that disrupting MTs in b cells disturbed GSIS (Ma-
laisse et al., 1974; Suprenant and Dentler, 1982). Brinkley’s
group, who studied insulin secretion using disseminated cell cul-
ture from thewhole pancreas, proposed amodel whereby insulin
granules residing in the cell interior are transported toward secre-
tion sites along radial MT arrays (Boyd et al., 1982). This model
appears plausible, because in many cell types long-distance
secretory membrane trafficking utilizes MT tracks, which extend
radially from the cell center to the periphery. However, while
MT-dependent motors indeed continuously translocate insulin
granules along MTs (Heaslip et al., 2014; Varadi et al., 2002,
2003), the radial MT tracks reported in pancreatic cells by Boyd
et al. (1982) were not confirmed by later studies: in b-cell lines
MTs form a complex non-directional mesh (Heaslip et al., 2014;
Varadi et al., 2002), poising challenges for directional cargo trans-
port. Furthermore, the importance of MTs for GSIS has been
questioned by recent experimental (Mourad et al., 2011) and
computational (Tabei et al., 2013) studies, which showed that
MTs are not required for GSIS and that random, diffusion-like
movement rather than directional transport accounts for vesicu-
lar delivery in b cells, respectively.
MT-dependent insulin granule transport has been best studied
utilizing total internal reflection fluorescence (TIRF) microscopy
in b-cell culture models (Heaslip et al., 2014; Hoboth et al.,
2015; Varadi et al., 2003). It has become clear that recently
generated (‘‘young’’) insulin granules, competent of release,
are moved along the cell membrane in a MT-dependent manner
(Hoboth et al., 2015). Such lateral insulin granule transport is
driven by the interplay of MT plus end-directed kinesin-1 and
MT minus end-directed cytoplasmic dynein (Varadi et al.,
2002, 2003). Unfortunately, because TIRF only visualizes granule
movement parallel to the plasmamembrane, the full role of MT in
the movement of insulin granules from the cell center to the cell
periphery is still unclear.
Several technical challenges hinder the analysis of MT
structure-function relationships in b cells. On one hand, analysisevier Inc.
(legend on next page)
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of complex MT organization and dynamics requires modern
high- and super-resolution microscopy, which have limited ca-
pacities in resolving thick samples, such as intact islets. On the
other hand, dissociated primary b cells rapidly de-differentiate
in culture and cultured b-cell lines usually have compromised
GSIS. This precludes most thorough microscopy studies from
direct assessment of MT function in GSIS in functional b cells
and raises concerns that altered MT structure and regulatability
may accompany b-cell de-differentiation.
Taking into account our findings on Golgi-derived MTs in
secretory cells (Efimov et al., 2007), we revisit MT structure
and function in insulin secretion, analyzing intact pancreatic
islets by high- and super-resolution microscopy, in combina-
tion with direct detection of in vitro and in vivo GSIS. We
uncover a surprising, yet critical, MT function in b cells in pre-
cisely controlling GSIS and suggest that disturbance of this
control may contribute to b-cell dysfunction in type 2 diabetes
mellitus.
RESULTS
Differentiated b Cells Contain Dense MT Meshwork
Derived from the Golgi Complex
Because MTs serve as tracks for intracellular trafficking, spatial
organization of MTs underlies their cellular function. To analyze
the 3D MT network in functional b cells within murine pancreatic
islets, we applied super-resolution structural illumination micro-
scopy (SIM), which allows for the optical resolution up to 100 nm.
b-cell MTs comprise a multi-directional, mesh-like network (Fig-
ures 1A and 1A’), similar to that in MIN6 b cells (Varadi et al.,
2003). Insulin granules (3–400 nm in diameter, see Olofsson
et al., 2002) were often observed constrained within the open-
ings of the MT network (Figure 1B), which had average spacing
of 484 ± 40 nm. Such high MT density was predominantly
observed in b cells, but not d cells (Figure 1C), suggesting that
dense MT meshwork is typical for b cells. Such MT organizationFigure 1. Dynamics of Dense Golgi-Derived MT Network in Pancreatic
(A and B) SIM images of murine islet b cells at 2.8 mM glucose, insulin (red) and
constrained between MTs, as shown in (B) by orthogonal views of the boxed are
(C) Confocal image of murine islet. The MTs in b cells (red outlines) are denser than
(D–E’) Immunostained primary b cells (insulin, blue) 90 s after nocodazole washout
nucleated from the Golgi mini-stacks (GM130, red). The centrosome-nucleatedM
in (D) and (E) are zoomed in (D’) and (E’). See also Movie S1.
(F and G) Live-cell confocal imaging of INS-1 cells at 3 mM (F) or 20 mM (G) gluco
Themultiple MT plus ends (EB3-GFP, green) extend from theGolgi (RFP-TGN, red
green, shown by yellow arrows). See also Movies S2 and S3.
(H) High glucose (20 mM) stimulates MT nucleation from the Golgi in primary b cel
(I) Steady-state MT nucleation at the Golgi is significantly enhanced by 2.8 mM
F and G).
(J and K) SIM images of MT organization in murine islet b cells at 2.8 mM (J) and 2
right corner) (insulin, red and tubulin, green).
(L and M) Confocal images of stable MTs remaining after short 30 min nocodazo
(insulin, red and tubulin, cyan).
(N and O) Confocal images of immunostained Glu-tubulin at 2.8 mM glucose (N) a
(P) Histogram distribution of spaces betweenMTs at low (2.8 mM) or high (20 mM
cells) (based on SIM images).
(Q) High glucose decreases tight MT spacing in both human and mouse islet b c
(R) High glucose increases large MT spacing in both human and mouse islet b c
(S) Fluorescence intensity of immunostained Glu-tubulin (as in N andO) is decreas
and O). In (H), (I), and (Q)–(S), mean ± SEM are shown.
658 Developmental Cell 34, 656–668, September 28, 2015 ª2015 Elsis remarkably different from that of most other cell types, where
MTs are nucleated at the centrosome-based MT-organizing
center (MTOC) and extend to the cell periphery in a radial fashion
(Alberts et al., 2002).
To understand how this unusual MT configuration arises,
we analyzed MT nucleation in primary b cells by nocodazole
washout assays. After complete MT depolymerization by noco-
dazole, the drugwas removed and sites of de novoMT formation
were detected. Interestingly, the number of MTs found at the
centrosome was relatively low; instead, the majority of MTs in
b cells emerged from the Golgi complex (Figures 1D, 1E, and
1H and Movie S1). This finding was confirmed by live-cell imag-
ing of newMT formation in non-treated (steady-state) INS-1 cells
(Figures 1F, 1G, and 1I), indicating that the Golgi acts as the
major MTOC in pancreatic b cells.
Glucose Regulates MT Nucleation and Dynamics in b
Cells
To address whether the unique MT organization in b cells con-
tributes to their response to glucose, we tested whether glucose
stimulation affects the MT network. Strikingly, high glucose
dramatically enhances new MT nucleation from the Golgi, but
not the centrosome (Figures 1E and 1G–1I and Movies S2 and
S3). Importantly, this effect was specific for b cells, since it
was observed in both primary b cells and INS-1 cells, but not
retinal pigment epithelial cells (RPE1) (Figure 1H), which also
contain Golgi-derived MTs (Efimov et al., 2007).
Unexpectedly, the glucose-enhanced MT nucleation did
not lead to increased MT density in b cells, in either murine
or human islets (Figures 1J, 1K, S1A, and S1B). In fact, high
glucose decreased MT density: fewer small MT mesh open-
ings (diameter <240 nm) and more large MT mesh openings
(>600 nm) were detected under high glucose conditions (Fig-
ures 1P–1R and S1C). This result suggests that high glucose
induces depolymerization of pre-existing MTs simultaneously
with the MT nucleation boost. Indeed, high glucose treatmentb Cells Are Facilitated by Glucose
tubulin (green). The box from (A) is enlarged in (A’). The insulin granules are
a from (A).
in d cells (white outlines), insulin (red), tubulin (green), and somatostatin (blue).
at 2.8mM (D) or 20mM (E) glucose. Thewhite arrows showMTs (tubulin, green)
T asters are shown by yellow arrows in the image. TheMT andGolgi from boxes
se. The boxes for whole cell overviews (left) are enlarged as time frames (right).
, shown bywhite arrows) and fewMTs grow from the centrosome (GFP-centrin,
ls (n = 7–10) and INS-1 (n = 11–13), but not RPE1 (n = 8) (asterisks, p < 0.0001.)
to 20 mM glucose switch (asterisks, p < 0.05) (n = 7–11) (based on data as in
0 mM glucose (K). The MT images are zoomed from boxes in overviews (upper
le treatment in 2.8 mM glucose (L) or 20 mM glucose (M) in murine islet b cells
nd 20 mM glucose (O) in murine islet b cells (insulin, red and Glu-tubulin, cyan).
) glucose conditions for mouse islet b cells (n = 5,490–5,503 spaces from 23–26
ells (asterisks, p < 0.0001) (n = 17–26 cells).
ells (asterisks, p < 0.0001) (n = 17–26 cells).
ed in high glucose (asterisks, p < 0.0001) (n = 68–77 cells) (based on data as in N
evier Inc.
Figure 2. MT Depolymerization Enhances and MT Stabilization Blocks GSIS
(A) Static GSIS over 45 min in nocodazole (red) or DMSO (blue) pre-treated islets. The glucose concentrations of 2.8 mM (low) or 20 mM (high) are shown
(asterisks, p < 0.005) (equals sign, p > 0.5) (n = 6 experiments). Here and below, static GSIS is shown as the percent of total insulin content after 45 min of
treatment, which did not differ between DMSO and drug-treated islets (Table S1).
(B) Time course of GSIS in nocodazole (red) or DMSO (blue) pre-treated islets (asterisk, p < 0.05) (double asterisks, p < 0.01) (n = 8 experiments). Themean ± SEM
are shown.
(C) A representative sequence illustration of a single secretion event. Note that a FluoZIn-3 signal is detected in a single frame.
(D) Secretion events quantified as FluoZin-3 fluorescence flashes in TIRFmicroscopy field in intact flattened islets in high glucose. The number of events per frame
per mm2 is shown as mean ± SEM (p < 0.005) (n = 5 islets) (based on data as in Movie S4).
(E and F) Maximal intensity projection overlays of FluoZin-3 imaging sequences over 100 s. The frequency of secretion events is strongly enhanced in nocodazole
(F) and compared to DMSO (E). See also Movie S4.
(G and H) Confocal images of immunostained pancreatic tissue sections from mice subjected to control (G) and colchicine (H) injections (tubulin, green and
insulin, red). The MTs are significantly destroyed in colchicine-injected mice (H) (arrow, primary cilia).
(I) Glucose tolerance in mice is improved after colchicine injection.
(J) Serum insulin content after glucose stimulus is increased after colchicine injection.
(I and J) Mean ± SEM are shown (n = 16 mice).
(K) GSIS after initial MT destabilization measured by perfusion with pancreatic islets. The nocodazole (5 mg/ml, red) or DMSO (blue) was added together with high
glucose (n = 4 experiments).
(L) Static GSIS over 45min in taxol (red) or DMSO (blue) pre-treated islets. The glucose concentration of 2.8mM (low) or 20mM (high) is shown (asterisks, p < 0.05)
(n = 6 experiments). The mean ± SEM are shown.decreased both MT resistance to the MT-depolymerizing
drug nocodazole (Figures 1L and 1M) and tubulin detyrosina-
tion (a post-translational modification indicative of long MT
lifetime, see Janke and Bulinski, 2011) (Figures 1N, 1O, and
1S). This means that MTs in glucose-stimulated b cells are
short-lived and must be replaced by newly polymerized MTs
to maintain the MT network. We conclude from these data
that MT dynamic turnover, which includes both polymerization
and depolymerization of MTs, is triggered by increased
glucose.DevelopmenMT Depolymerization Facilitates GSIS In Vitro and
In Vivo
Our finding that MTs dynamics responds to glucose, led us to
revisit the role of MTs in GSIS from whole islets, in which MTs
have been depolymerized by nocodazole (Figures S1D–S1G).
Surprisingly, complete MT disruption by 2 hr pre-incubation in
nocodazole strongly increased islet GSIS, but did not alter basal
insulin secretion (Figures 2A and 2B). This effect was specific for
b cells since somatostatin secretion from d cells was not
enhanced in nocodazole-pre-treated islets (Figure S2A).tal Cell 34, 656–668, September 28, 2015 ª2015 Elsevier Inc. 659
To test whether detected insulin content in the medium corre-
lates with the secretion rate rather than non-specific effects
(e.g., cell lysis), we used FluoZin-3, a cell-impermeable dye
that becomes instantly fluorescent upon Zn2+-binding, and is
used to detect secretion of Zn2+-rich insulin granules (Gee
et al., 2002). To detect insulin secretion in intact live islets, we
applied fast TIRF imaging to ‘‘flattened islet’’ cultures where
robust GSIS was maintained (Supplemental Information) and
recorded insulin secretion events, which manifested as peaks
of FluoZin-3 fluorescence (Figure 2C). This approach showed
a strong increase in secretion events in islets pre-treated with
nocodazole (Figures 2D–2F and Movie S4; Table S2), indicating
that MT depolymerization promotes GSIS via increased secre-
tion activity.
We have further addressed the place of MT-dependent
regulation within known physiological regulation of insulin
secretion. MT regulation of GSIS proved not to be a part of
the incretin-dependent pathway (Efendic and Portwood,
2004), since nocodazole further enhances GSIS after it has
been potentiated by glucagon-like peptide (GLP-1, a major
GSIS-amplifying gut hormone of the incretin group; Fig-
ure S2B). Indeed, the effects of high glucose on MT network
density and stability were not influenced by GLP-1 (Figures
S2C–S2M). Moreover, nocodazole significantly enhanced
insulin secretion induced by arginine, KCl, tolbutamide, and
IBMX (secretagogues that are known to stimulate insulin
secretion via depolarizing b-cell membrane [arginine, KCl,
tolbutamide] or via enhancing intracellular cyclic (c)AMP levels
[IBMX]; see Sharp, 1979; Wollheim and Sharp, 1981; Figures
S2N and S2O). These data indicate MT destabilization affect
insulin secretion at distal regulatory steps, such as vesicle
localization.
As a next step, we tested whether MT disruption in organisms
has a physiologically significant effect on insulin secretion and
blood glucose levels. We injected mice with colchicine, a less
toxic MT-depolymerizing Food and Drug Administration (FDA)-
approved drug, which disrupted MTs in tissues, including b cells
(Figures 2G and 2H). This manipulation significantly improved
glucose clearance in mice (Figure 2I) and enhanced levels of
plasma insulin (Figure 2J), in agreement with the effect on iso-
lated islets.
These data allowed us to conclude that MT depolymerization
enhances GSIS, which bears significance in glucose homeosta-
sis in vivo, and prompted a counterintuitive hypothesis that MTs
restrict, rather than enhance, the number of insulin granules
available for secretion. Interestingly, we found that even initial
MT depolymerization as early as 5 min after nocodazole addition
caused GSIS enhancement in experiments where nocodazole
was added simultaneously with high glucose stimulation (Fig-
ure 2K). This suggests that insulin secretion is very sensitive to
MT presence and partial MT depolymerization in frame of
glucose-triggered MT destabilization (Figures 1J–1S) might in-
crease the releasable insulin pool; if this is correct, blocking
MT depolymerization must decrease GSIS. Consistent with this
hypothesis, taxol-induced MT stabilization strongly inhibited
GSIS (Figures 2L, S1H, and S1I), confirming published results
(Howell et al., 1982; Mourad et al., 2011). This indicates that
the capacity of MTs to depolymerize is a critical requirement
for insulin secretion.660 Developmental Cell 34, 656–668, September 28, 2015 ª2015 ElsMTsWithdraw Insulin Granules from the Cell Membrane
to Reduce Secretion
Because MT disruption enhances GSIS (Figure 2), we hypothe-
sized that MTs prevent excessive secretion by withholding insu-
lin granules or withdrawing them from the cell periphery.
To test this hypothesis, we visualized insulin granule behavior
at the cell membrane in b cells within intact islets. The islets were
derived from transgenic mice expressing an insulin-mCherry
fusion protein specifically in b cells that did not interfere with b
cell function (Figures S4A–S4D). Conveniently, insulin-mCherry
was incorporated into insulin granules in a mosaic manner, high-
lighting a random subpopulation (approximately 7%) of granules
that allowed for their easy tracking. Because TIRF optical
sectioning visualizes the 200 nm-thick lowest cell’s layer, it
allowed us to analyze lateral granule movement parallel to the
ventral cell membrane (Figures 3A–3D and Movies S5 and S6).
We found that the majority of granules underwent minimal lateral
displacements (<1 mm). Additionally, a subset of granules ex-
hibited fast, randomly directed lateral movements, which were
eliminated by nocodazole (Figure 3E), and thus were MT-depen-
dent, consistent with the data from cell lines (Heaslip et al., 2014;
Varadi et al., 2002).
Furthermore, TIRF experiments allowed us to analyze the dy-
namics of granule delivery to, and disappearance from, the cell
periphery. Disappearance of granules from the TIRF field is likely
due to a combination of secretion and withdrawal of granules
back to the inner cytoplasm. However, insulin secretion is a
rare event, although a substantial number of vesicles can be de-
tected near the plasma membrane (Rorsman and Renstro¨m,
2003). Indeed, our quantification of the secretion events fre-
quency using FluoZin-3 dye (Figures 2C–2E) showed that
because insulin-mCherry highlights only a fraction of all insulin
granules, the number of observed secretions of insulin-mCherry
was extremely low (< 1.4 mCherry-labeled granules per min per
movie). This allowed us to neglect the share of secretion in quan-
tification of insulin-mCherry granule behavior and approximate
that the insulin-mCherry granule disappearance represents
granule withdrawal from the cell border.
Interestingly, we found that without glucose stimulation, the
number of insulin-mCherry granules at the cell surface was con-
stant both in control and MT-depleted cells. Also, when insulin
secretion was stimulated in control cells, the overall number of
granules in the TIRF field did not change (Figures 3F and3H; Table
S2), indicating that the number of granules delivered from the cell
center was precisely balanced with the granules withdrawn (and
secretion, to a lesser degree). In contrast, in islets pre-treated
with nocodazole to eliminate MTs, the number of insulin granules
in the TIRFfieldwasdramatically andcontinuously increased (Fig-
ures 3G and 3H and Movie S6), indicating that the balance
between insulin granule delivery and withdrawal was disturbed.
Specifically, the share of granules disappearing from the field of
view (as in Figures 3K and 3L)was reduced in nocodazole-treated
cells as compared tocontrol (Figure3I),while granule deliverywas
unchanged (Figure 3J; Table S2). We conclude that, in the
absence of MTs, granules fail to withdraw from the cell border;
this leads to accumulation of insulin granules at the cell periphery
and unregulated increase of the pool available for secretion. In
contrast, normally, MTs provide a regulatory mechanism that
balances the number of delivered and withdrawn granules.evier Inc.
Figure 3. Lack of MTs during GSIS Interferes with Insulin Granule Withdrawal from the b-Cell Periphery
(A–D) Tracks of lateral insulin granulemovement recorded by live TIRFmicroscopy of flattenedRipmCherry islets in (A) DMSO+ 2.8mMglucose, (B) DMSO+ 20mM
glucose, (C) nocodazole + 2.8mMglucose, and (D) nocodazole + 20mMglucose. The number of tracks with final displacement >0.77 mm (light gray) is decreased
after nocodazole treatment. See also Movies S5 and S6.
(E) Long distance lateral movement of granules is blocked by nocodazole (2.8 mM glucose) (n = 5,494–6,230 tracks). The whole population percentage is shown
(asterisks, p < 0.0001).
(F and G) Live TIRF microscopy of intact islets. The glucose stimulation does not change the number of mCherry-insulin granules in the TIRF field in DMSO
(F, dotted circles), but dramatically increases it in nocodazole (G, dotted circles) (time after stimulation, min).
(H) Percent increase of insulin granules number in TIRF field under four conditions as in (A)–(D). Only nocodazole + 20mM glucose leads to granule accumulation.
The mean ± SEM are shown.
(I and J) Number of granules withdrawn from the TIRF field (I) within 1 min is decreased and number of granules delivered (J) is unchanged in nocodazole. The
mean percentage ± SEM of insulin-mCherry-labeled granules in the field is shown (double asterisk, p < 0.005) (equal sign, p > 0.1) (n = 16 1-min movies from four
islets).
(K and L) Representative kymographs (single-line intensity scans over time) of granules live in the TIRF field. In DMSO (K), granules are rapidly delivered to the
membrane (acute appearance, single arrow) and withdrawn after a short dwelling period. Note that the withdrawal is accompanied with a lateral granule shift
(double arrow). In nocodazole (L), granules are delivered by slow diffusion (slow signal increase, single arrow) and dwell at the membrane throughout the movie
(double arrow) (time, s).MT and Actin Cytoskeletons Cooperate to Control GSIS
The surprising stimulating effect of MT depolymerization on
GSIS resembles the well-established reaction of b cells to actin
cortex disassembly, which leads to dramatic enhancement ofDevelopmenGSIS (Li et al., 1994; Thurmond et al., 2003; Wang and Thur-
mond, 2009). Because functional interplay of MT and actin cyto-
skeletons has been described in many cellular contexts (Goode
et al., 2000), we tested whether MT depolymerization leads total Cell 34, 656–668, September 28, 2015 ª2015 Elsevier Inc. 661
Figure 4. MTs and Actin Interplay to Regulate GSIS
(A–D’) Confocal images of mouse islets immunostained for insulin (red) and actin (phalloidin, green) after nocodazole treatment. The actin images from boxes
in (A)–(D) are zoomed in (A’)–(D’). The intensity of the actin cortex at the cell borders (arrows) is diminished by high glucose (B’ and D’) as compared to low glucose
(A’ andC’, respectively). The actin bundles in the cell interior (asterisks) are slightly increased in nocodazole treated cells (C’ andD’) as compared toDMSO (A’ and
B’, respectively).
(E–H’) Confocal images of mouse islets immunostained for insulin (red) and tubulin (green) after Latrunculin B treatment. The MT images from boxes in (E)–(H)
are zoomed in (E’)–(H’). The MT density is decreased by high glucose (F’) and by Latrunculin B (G’ and H’).
(I) Static GSIS over 45 min in DMSO (blue), nocodazole (red), Latrunculin B (green), and nocodazole + Latrunculin B (yellow) pre-treated islets. The glucose
concentrations of 2.8 mM (low) or 20 mM (high) are shown (asterisks, p < 0.01) (n = 8 experiments). The mean ± SEM are shown.
(J) Latrunculin B decreases tight MT spacing in mouse islet b cells at both low and high glucose levels (double asterisks, p < 0.0001) (asterisk, p < 0.05)
(n = 30–37 cells).
(K) Latrunculin B increases large MT spacing in mouse islet b cells at both low and high glucose levels (double asterisks, p < 0.0001) (asterisk, p < 0.01)
(n = 30–37 cells).
(J and K) Data are based on a histogram (data not shown) as in Figure 1P. The mean ± SEM are shown.partial destruction of the actin cortex in b cells, providing
a mechanism for GSIS enhancement. Nocodazole slightly
enhanced actin bundling in the cytoplasm (Figures 4A–4D),
which is not surprising given known activation of small GTPase662 Developmental Cell 34, 656–668, September 28, 2015 ª2015 ElsRhoA downstream of MT depolymerization (Chang et al.,
2008). However, we did not detect alterations in the actin cortex
at the cell boundary in nocodazole- versus DMSO-treated islets
under either low or high glucose conditions (Figures 4A–4D). Weevier Inc.
concluded that it is unlikely that MT destabilization facilitates
GSIS via actin cortex disassembly. Interestingly, further investi-
gation of potential cytoskeletal crosstalk showed that actin
depolymerization by Latrunculin B does cause significant loos-
ening of the MT network (Figures 4E–4H’), to the level similar
or above the loosening caused by the high glucose trigger (Fig-
ures 4J and 4K). Moreover, GSIS in Latrunculin B-treated islets
was stronger than in nocodazole-treated islets and was not
further enhanced by nocodazole (Figure 4I), suggesting that
MT destabilization is one of the pathways that contributes to
GSIS facilitation downstream of actin disruption. On the other
hand, MT loosening in LatrunculinB-treated islets was further
facilitated by high glucose (Figures 4J and 4K), indicating that
physiological MT destabilization likely involves an additional,
actin-independent mechanism.
Cytoskeleton-Driven Granule Transport Is Not Required
for Insulin Secretion
Our data indicate that while MT disruption enhanced GSIS by
blocking insulin granule withdrawal from the cell periphery, their
delivery from the inner cytoplasm was unchanged. Disruption of
the actin cytoskeleton also facilitates GSIS (Kalwat and Thur-
mond, 2013), raising a question whether cytoskeleton-depen-
dent transportation of granules from the cell interior to the cell
periphery is at all required for secretion. To address this, we
followed 3D movement of granules in insulin-mCherry-express-
ing islets visualized by high-resolution confocal microscopy.
Granule movement was subsequently analyzed by automatic
tracking (Figures 5A–5I). Mean square displacement (MSD) anal-
ysis was used to analyze the whole granule population (Fig-
ure 5J); maximal track displacement of 0.4 mm and more was
used to distinguish granules undergoing active transportation.
We found that movement of insulin granules under all conditions
was non-directional and fitted to the subdiffusion motion type
(Saxton, 2007) (see Supplemental Information). In the absence
of MTs, granules remained motile, indicative of an actin-depen-
dent transportation mechanism. Indeed, in the absence of both
cytoskeletal networks, granule displacement over 0.4 mm was
a rare event.
The percentage of motile granules was increased by high
glucose (Figure 5K). Interestingly, this increase was absent after
MT disruption (Figure 5K), suggesting that glucose-driven
regulation of transport requires MTs, which is consistent with
previous findings (Donelan et al., 2002; Heaslip et al., 2014).
Disruption of actin facilitated MT-dependent movement, but
did not block glucose-dependent regulation of granule move-
ment (Figure 5K).
These data agree with the previously proposed model where
MTs and actin collaborate to drive non-directional insulin granule
transport, based on observations in cell lines (Heaslip et al.,
2014; Hoboth et al., 2015; Tabei et al., 2013); thus, these prior
conclusions can be extrapolated into 3D granule transportation
in intact islets. More importantly, we show that the ability of the
cytoskeleton to displace granules does not correlate with high
GSIS (Figure 4I). Rather, excessive secretion occurs when cyto-
skeletal elements are absent and/or loosened. We conclude
that active transport of insulin granules is not required for GSIS
and rather served for fine regulation of granule availability for
secretion.DevelopmenOverly Dense MTs in Dysfunctional b Cells Prevent
Insulin Secretion
Our data indicate that the dense MT network in b cells acts
to restrict GSIS, which means that unregulated increase in MT
density might interfere with b-cell function in organisms. To
determine whether alteration of the MT network is associated
with diabetes, we compared dysfunctional b cells within pancre-
atic tissue sections from diabetic (db/db) mice (blood sugar >
350 mg/dl) with b cells of wild-type (WT) or healthy heterozygous
control (db/+) mice by SIM. Strikingly, MTs in tissue sections
(Figures 6A and 6B) and islets derived from db/db mice (Fig-
ure S5) were overly dense; the openings of the MT mesh were
significantly smaller in db/db b cells than in controls (Figures
6C–6E). According to our model, abnormally high MT density
reduces granule availability for release at the cell periphery.
Indeed, after MT depolymerization by nocodazole, GSIS by
db/db islets was significantly enhanced (Figure 6F), although
not restored to WT levels. Vice versa, stabilization of MTs by
taxol significantly decreased GSIS (Figure 6F), indicating that
glucose-stimulated MT dynamics are required for insulin release
from db/db b cells and that MT regulation of GSIS is still func-
tional. We conclude that a pathway, which includes MT control
of GSIS, is not blocked in this disease model; however, MT-
dependent restriction of GSIS is overly active in db/db mice. It
is possible that the elevated MT density arises as a protective
mechanism to prevent depletion of insulin granules when b cells
hyper-secrete insulin to counteract insulin resistance of db/db
mice (Orland and Permutt, 1987) and serves as one of the
mechanisms of disease progression.
DISCUSSION
The work presented here leads to a surprising conclusion
that the major function of MT-based transport in b cells is to limit
the number of insulin granules available for secretion on a given
stimulus. The granule number at the cell periphery is controlled
by constant removal of granules, moving along a non-directional
MT network, regulated via glucose-dependent MT destabiliza-
tion and Golgi-derived MT nucleation (Figure 7). Without MT
control (in nocodazole), granules undergo excessive docking
and secretion upon stimuli; in vivo, this over-secretion increases
blood glucose clearance.
Amain finding of our study is that physiological glucose desta-
bilizes MTs in subcellular domains in b cells, resembling a local
nocodazole effect. We hypothesize that such local MT depoly-
merization close to the plasma membrane creates a pool of
MT-unattached granules, available for docking and secretion.
Additional granule delivery is dispensable for this process,
because insulin granules are abundant at the cell periphery,
and only a small percentage is secreted on a given stimulus
(Rorsman and Renstro¨m, 2003). While granule movement does
not actively move toward the plasma membrane in the absence
of MTs (Table S2), diffusion is sufficient for granule relocation to
the docking sites. In the absence ofMT-motor-driven withdrawal
force, granules have sufficient time to be tethered and docked.
As a result, MT destabilization becomes critical for GSIS
and likely serves to precisely regulate secretion. This model
incorporates the views that granule tethering/docking is an
active glucose-dependent process that defines the number oftal Cell 34, 656–668, September 28, 2015 ª2015 Elsevier Inc. 663
Figure 5. MTs and Actin Collaborate to Non-directionally Translocate Insulin Granules in Mouse Islets
(A–H) Examples of 3D movement tracks of mCherry-labeled insulin granules, recorded by spinning disk confocal microscopy. The pre-treatment: (A and B)
DMSO, (C and D) nocodazole, (E and F) Latrunculin B, and (G and H) nocodazole + Latrunculin B. The glucose concentration: (A, C, E, and G) 2.8 mM (low) and
(B, D, E, and H) 20 mM (high). The z axis is color coded as indicated in (I). See also Movies S7 and S8.
(J) MSD analysis of insulin dynamics at conditions as in (A)–(H). The insulin exhibits subdiffusionmovement in all conditions. Themovement velocity is dramatically
decreased upon disruption of MTs (red) and even more so upon disruption of both MTs and actin (yellow) (n = 2,087–9,370 tracks from four islets). The mean ±
SEM are shown.
(K) Percentage of motile granules (maximal 3D track displacement over 0.4 mm) upon disruption of the cytoskeleton. The glucose-dependent regulation of granule
motility is not detected in nocodazole (n = 3,724–9,370 tracks). The whole population percentage is shown (asterisks, p < 0.0001) (equals sign, p > 0.1).secretion-competent granules and requires a distinct (likely
short) period when a granule is stationary in the vicinity of the
docking machinery (Rorsman and Renstro¨m, 2003).
A critical requirement for efficient granule withdrawal from the
secretion sites is a very dense MT network, which supports non-
directional granule movement, or ‘‘random walk’’ (Tabei et al.,
2013). Golgi-derived nucleation is a potent mechanism for
such network formation, because the Golgi in b cells is relatively664 Developmental Cell 34, 656–668, September 28, 2015 ª2015 Elslarge and extends across a large part of the cytoplasm (Kanaani
et al., 2015; Marsh et al., 2004; Sumara et al., 2009), providing
multiple nucleation sites for a dense multi-directional MT
network. Additionally, granules undergo non-directional move-
ments switching between close tracks, which traps them in the
b-cell interior. Glucose-dependent MT turnover in the cell center
might remove restrain of trapped granules to contribute to
GSIS enhancement. This function is similar to actin-dependentevier Inc.
Figure 6. b-Cell MT Network Is Denser in
db/db Mice Than in WT
(A–B’) b cells in tissue sections from WT (A and A’)
and db/dbmice (B and B’). SIM images are shown
in the images. The yellow dashed lines indicate cell
outlines. The MTs from boxes in (A) and (B) are
zoomed in (A’) and (B’). The arrows indicate typical
MT spacing.
(C) Histogram distribution of spaces between
MTs in b cells in db/+ and db/db islets (n = 1,972–
2,303 spaces from 30 cells) (based on SIM
images).
(D) Tight MT spacing is increased in b cells
from db/db islets as compared to db/+ (asterisks,
p < 0.0001) (n = 30 cells).
(E) Large MT spacing is decreased in b cells
from db/db islets as compared to db/+ (asterisks,
p < 0.0001) (n = 30 cells).
(F) Static GSIS over 45 min in DMSO, nocodazole,
and taxol pre-treated islets from 4-month-old
db/+ and db/db mice (n = 8–12 experiments). The
glucose concentrations of 2.8 mM (low) or 20 mM
(high) are shown (asterisk, p < 0.05) (double
asterisk, p < 0.01) (bracketed asterisk, p < 0.1). In
(D)–(F), mean ± SEM are shown.restriction of transport described both for insulin granules (Heas-
lip et al., 2014; Hoboth et al., 2015) and pigment granules in me-
lanocytes (Semenova et al., 2008; Wu et al., 1998). It is also clear
that MTs tightly collaborate with the actin cytoskeleton to control
insulin granule availability for secretion (Heaslip et al., 2014;
Hoboth et al., 2015); here, we show that, as a part of this inter-
play, actin influences the density of MT network in b cells. This
possibly occurs because MT ends can be stabilized by actin-
dependent capture (Gundersen et al., 2004).
Importantly, we show that during GSIS, glucose-driven MT
destabilization is balanced by new MTs formed at Golgi mem-
branes, which likely prevents over-secretion of insulin. AlongDevelopmental Cell 34, 656–668, Sethe same lines, MT plus end growth rates
are increased under high glucose condi-
tions in INS-1 cells (Heaslip et al., 2014).
These data indicate that b-cell MTs play
the role of cellular ‘‘rheostat’’, which is
tuned according to physiological needs
by modulating the density and dynamics
of the MT meshwork, and precisely
meters insulin release under a specific
stimulus.
It is important to understand how facil-
itation of GSIS by reduction of MT den-
sity, reported here, is coordinated with
the action of MT motors. Our, and previ-
ous observations (Tsuboi and Rutter,
2003; Varadi et al., 2003), indicate that
both granule withdrawal into inner cyto-
plasm and lateral movements along the
plasma membrane can move granules
away from the secretion sites. In princi-
ple, movement of granules toward either
MT end (e.g., kinesin-1 or dynein-driven,see Varadi et al., 2003) can either deliver or withdraw a granule
from the secretion site becauseMT network in b cells lacks radial
organization, and granules move chaotically. High glucose stim-
ulus leads to activation of kinesin-1 (Donelan et al., 2002; McDo-
nald et al., 2009) and MT-dependent granule movement. Our
data suggest that more active movement should further restrict
the time that granules spend at the docking sites where they
are available for secretion. We hypothesize that in stimulated b
cells where docking/priming of granules is strongly activated,
over-secretion might occur without activation of MT-dependent
withdrawal. On the other hand, depletion/inhibition of kinesin-1,
as well as kinesin-1 knockout in mice, suppresses GSIS (Cuiptember 28, 2015 ª2015 Elsevier Inc. 665
Figure 7. A Model of the Rheostat Function of MTs in b Cells
Dense MTs trap insulin granules in the cell center and promote their random
walk. Non-directional granule movement leads to rapid granule withdrawal
from the cell periphery, balanced with granule arrival. Glucose stimuli trigger
both MT nucleation and destabilization. MT destabilization in the cell center
reduces trapping. MT destabilization at the cell periphery decreases frequency
of withdrawal and leads to free diffusion of detached granules, allowing for
their docking. Enhanced MT nucleation at the Golgi balances MT destabili-
zation, leading to fine rheostat regulation of granule availability for release.et al., 2011; Donelan et al., 2002; McDonald et al., 2009; Meng
et al., 1997). This might be explained by the presence of other
molecular motors of the granule surface, which can hold gran-
ules at MTs when kinesin is blocked (Ally et al., 2009; Bryantseva
and Zhapparova, 2012). In this case, granules would not become
detached fromMTs and available for secretion without kinesin-1.
Indeed, inactivation of kinesin-1 has no effect on net localization
of insulin granules within b cells (Cui et al., 2011).
While our findings and model are in line with recent findings
describing MT motor-dependent transport of insulin granules
(Heaslip et al., 2014; Hoboth et al., 2015; Tabei et al., 2013; Var-
adi et al., 2003), they do not agree with several previous studies
showing decreased GSIS after MT disruption (Boyd et al., 1982;
Malaisse et al., 1974; Suprenant and Dentler, 1982). Given the
consistency of our observations ranging from single cells to
whole animals, such discrepancy can be potentially explained
by the variability in the experimental conditions for islet isolation,
in vitro culture, and insulin GSIS assay, which could have re-
sulted in variable MT reconfiguration and vesicular localization
to eliminate the effect of MT depolymerization. For example,
we show here (Figures S2N and S2O) that MT destabilization
enhances KCl–induced insulin secretion only after low glucose
pre-incubation, but not after pre-incubation in stimulatory
glucose.666 Developmental Cell 34, 656–668, September 28, 2015 ª2015 ElsOverall, our findings have important implications for the under-
standing of b-cell function and dysfunction. Importantly, we
found that b-cell MTs restrict GSIS in mice, indicating that the
rheostat mechanism is likely active in organisms. Dysfunctional
b cells in diabetic mice have abnormally high MT density; more-
over, the MT networks of murine and human b cells are remod-
eled by glucose similarly, suggesting a general MT-dependent
function relevant to human b-cell physiology. In light of our
data, several already FDA-approved MT-targeting anticancer
drugs (Perez, 2009) might be considered as possible therapeutic
interventions for diabetes.EXPERIMENTAL PROCEDURES
Mice utilization followed protocols approved by the Vanderbilt Institutional
Animal Care and Use Committee (IACUC). Most studies utilize islets from
WT mice with mixed genetic background. RipmCherry mice were derived by
pronuclear injection, with a 0.7 kb rat Insulin 2 promoter (Postic et al., 1999)
driving mCherry-insulin expression. The 10 week C57BL/KsJ db/db mice
and their littermates that were used to compare MT organization were from
Jackson Laboratory. Staining of sections and islets followed published
protocols (Matsuoka et al., 2010; Wang et al., 2008). Pancreatic islets were
handpicked after in situ collagenase perfusion and digestion. Human islets
were from the Integrated Islet Distribution Program. RPE1 and INS-1 832/
13 cells were cultured as previously described (Efimov et al., 2007; Hohmeier
et al., 2000). The flattened islets were used after more than 1 week, but less
than 2 weeks in culture, during which, the cultured islets maintain robust
GSIS: insulin secretion (in % of total insulin content) in flattened islets was
0.03 ± 0.0026% (basal) and 0.6 ± 0.0014% (stimulated), as compared to
0.02 ± 3.8 3 E05% (basal) /0.62 ± 0.001% (stimulated) in freshly isolated
islets (n = 4).
Islet perifusion and static GSIS assay were carried out as previously
described (Dai et al., 2012; Zhao et al., 2010). For perifusion, nocodazole
(5 mg/ml) was added simultaneously with glucose stimulation. For static
GSIS assay, nocodazole (10 mg/ml) or taxol (10 mM) were added to the pre-
incubation buffer and present throughout the experiments.
For immunofluorescence, islets were fixed with 4% paraformaldehyde.
Tissue culture cells were fixed with methanol at 20C. Immunofluorescence
followed described protocol (Mourad et al., 2011). 3D images were then
captured with a Leica TCS5p or DeltaVision OMX.
For live-cell imaging of MT dynamics, INS-1 cells were transfected with
GFP-centrin (centrosome), RFP-TGN (Golgi), GFP-EB3 (MT plus-end), and
imaged in 3 mM or 20 mM glucose by spinning disk confocal imaging system
described previously (Efimov et al., 2007). For insulin dynamics, flattened islets
from RipmCherry-mice were imaged in the presence of 2.8 mM or 20 mM
glucose by TIRF microscopy as described previously (Efimov et al., 2008).
To detect insulin secretion after glucose stimulation by FluoZin-3 (Gee et al.,
2002) (Figures 2C–2F and Movie S4), flattened islets were prepared and pre-
incubated with nocodazole or DMSO. Glucose and FluoZin-3 in Kreb’s Ringer
Buffer (KRB) buffer were added to the sample on the microscope stage to final
concentrations of 20 mM glucose and 20 mM Fluozin-3.
For MT regrowth after nocodazole washout, nocodazole was applied to fully
disassemble MTs and then washed out to allow for MT repolymerization.
For all fluorescence images presented, brightness, contrast, and gamma
settings for each individual fluorescence channel were adjusted to make small
structural features visible. Image analysis was done with Image J, Imaris, and
MatLab.
All the statistics were performed with MatLab software. All quantitative data
were collected from experiments performed in at least triplicate and expressed
asmean ± SEM. For data sets characterized by normal distribution, F-test was
performed to test for the equal variance, followed by t test. For data sets, which
did not follow normal distribution, Wilcoxon tests were performed to test the
statistical difference between the two groups. For categorical data (Figures
3E and 5K), chi-square test was performed. For the correlation between total
insulin content and IEQ, regression analysis was performed. Differences were
considered significant when p < 0.05.evier Inc.
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